Ebit Alterar Data
AbbVie USD 6.72B 1.99B 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amgen USD 4.61B 777M 2026-06
Arrowhead Research USD -141.26M 182.07M 2026-03
Astellas Pharma JPY 185.36B 136.79B 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 3.53B 2.42B 2026-03
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Daiichi Sankyo JPY 85.1B 4.44B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Incyte USD 700.4M 356.23M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Merck USD 840M 2.72B 2026-06
Moderna USD -815M 573M 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 4.73B 549M 2026-06
Novartis USD 4.18B 118M 2026-03
Pfizer USD -180M 5.16B 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06